• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

American Cancer Society, Roundtrip Partner to Enable Transportation for Cancer Patients

Share:

April 16, 2021

What You Should Know:

– Healthcare tech & ridesharing company Roundtrip has rolled out its platform with the American Cancer Society (ACS), specifically its ‘Road to Recovery program in order to enable cancer patients to connect to the treatment they need. The goal is to reduce the overall cancer mortality rate by 40% by 2035.

– Together, Roundtrip and ACS will work to ease the stressful process of transportation coordination and allow patients to focus on what is most important – their care and recovery.

– Roundtrip is a simple, comprehensive patient ride ordering software that connects patients with non-emergency medical transportation (NEMT). Roundtrip supports all levels of transport: volunteer drivers, rideshare, taxi, medical cars, wheelchair vans, stretcher vehicles, ALS/BLS ambulances, all payers, and all trips delivered when and where they are needed.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“The American Cancer Society is excited to leverage Roundtrip’s cutting-edge technology to assist patients in getting to life-saving treatment,” says Chuck Westbrook, Senior Vice President of Cancer Control Programs and Services at the American Cancer Society. “We are confident that our patients and volunteers will benefit from this new transportation solution that helps patients overcome barriers to timely and high-quality care.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Biosynth Carbosynth Further Expands Life Sciences Platform with Acquisition of Aalto Bio ReagentsBiosynth Carbosynth Further Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents
  • BioVaxys in Non-Binding Discussions for Major Immuno therapeutics Technology AcquisitionBioVaxys in Non-Binding Discussions for Major Immuno therapeutics Technology Acquisition
  • How The Cloud Will Revolutionize Your Healthcare NetworkHow The Cloud Will Revolutionize Your Healthcare Network
  • Soaak Technologies Announces Acquisition of Tulsa Natural Health Clinic, for its’ Global and Digital ExpansionSoaak Technologies Announces Acquisition of Tulsa Natural Health Clinic, for its’ Global and Digital Expansion
  • Genomic Data Carve A New Path For Consumers, Clinical TrialsGenomic Data Carve A New Path For Consumers, Clinical Trials
  • SAIC Unloads Logistics & Supply Chain Business Through Sale to ASRC Federal for $350MSAIC Unloads Logistics & Supply Chain Business Through Sale to ASRC Federal for $350M
  • OncoTracker Expands Multiple Myeloma Intellectual PropertyOncoTracker Expands Multiple Myeloma Intellectual Property
  • Global Chatbots In Healthcare Market To Reach $498M By 2029Global Chatbots In Healthcare Market To Reach $498M By 2029

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications